DK1357937T3 - Anvendelse af botulintoxin til opnåelse af et produkt til anvendelse ved ledpatologier, navnlig coxarthrosis, epicondylitis og drejemuskelkappepatologi - Google Patents

Anvendelse af botulintoxin til opnåelse af et produkt til anvendelse ved ledpatologier, navnlig coxarthrosis, epicondylitis og drejemuskelkappepatologi

Info

Publication number
DK1357937T3
DK1357937T3 DK02727002T DK02727002T DK1357937T3 DK 1357937 T3 DK1357937 T3 DK 1357937T3 DK 02727002 T DK02727002 T DK 02727002T DK 02727002 T DK02727002 T DK 02727002T DK 1357937 T3 DK1357937 T3 DK 1357937T3
Authority
DK
Denmark
Prior art keywords
coxarthrosis
epicondylitis
product
botulinum toxin
articular pathologies
Prior art date
Application number
DK02727002T
Other languages
Danish (da)
English (en)
Inventor
Corrado Marchini
Fabiano Pinat
Fabio Pinat
Francesca Zecchini
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11460457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1357937(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scras filed Critical Scras
Application granted granted Critical
Publication of DK1357937T3 publication Critical patent/DK1357937T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK02727002T 2001-01-05 2002-01-04 Anvendelse af botulintoxin til opnåelse af et produkt til anvendelse ved ledpatologier, navnlig coxarthrosis, epicondylitis og drejemuskelkappepatologi DK1357937T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2001UD000002A ITUD20010002A1 (it) 2001-01-05 2001-01-05 Uso della tossina botulinica per la soluzione di patologie articolari, in particolare della coxartrosi, della epicondilite e della patolo
EP02727002A EP1357937B1 (fr) 2001-01-05 2002-01-04 Utilisation de toxine botulinique dans la fabrication d'un produit utilise dans les pathologies articulaires, en particulier les coxarthroses, les epicondylites, et les pathologies de la tete du muscle rotateur
PCT/IB2002/000003 WO2002053175A2 (fr) 2001-01-05 2002-01-04 Utilisation de toxine botulinique dans la fabrication d'un produit utilise dans les pathologies articulaires, en particulier les coxarthroses, les epicondylites, et les pathologies de la tete du muscle rotateur

Publications (1)

Publication Number Publication Date
DK1357937T3 true DK1357937T3 (da) 2005-08-01

Family

ID=11460457

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02727002T DK1357937T3 (da) 2001-01-05 2002-01-04 Anvendelse af botulintoxin til opnåelse af et produkt til anvendelse ved ledpatologier, navnlig coxarthrosis, epicondylitis og drejemuskelkappepatologi

Country Status (15)

Country Link
US (2) US7208166B2 (fr)
EP (1) EP1357937B1 (fr)
JP (1) JP2004517114A (fr)
CN (1) CN1318089C (fr)
AT (1) ATE291437T1 (fr)
AU (1) AU2002222432B8 (fr)
CA (1) CA2433765C (fr)
CY (1) CY1105490T1 (fr)
DE (1) DE60203370T2 (fr)
DK (1) DK1357937T3 (fr)
ES (1) ES2242858T3 (fr)
IT (1) ITUD20010002A1 (fr)
PT (1) PT1357937E (fr)
RU (1) RU2283664C2 (fr)
WO (1) WO2002053175A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003009897A (ja) * 2001-07-03 2003-01-14 Keiji Oguma ボツリヌス毒素の分離・精製法
US7691394B2 (en) * 2002-05-28 2010-04-06 Botulinum Toxin Research Associates, Inc. High-potency botulinum toxin formulations
CA2510058C (fr) * 2002-12-20 2010-03-16 Botulinum Toxin Research Associates, Inc. Compositions pharmaceutiques de toxine botulique amelioree
US7666093B2 (en) * 2004-08-03 2010-02-23 Igt Gaming method and device involving progressive wagers
US8323666B2 (en) * 2005-08-01 2012-12-04 Allergan, Inc. Botulinum toxin compositions
WO2010096134A1 (fr) 2008-12-04 2010-08-26 Botulinum Toxin Research Associates, Inc. Formulation de toxine botulique à durée de vie prolongée pour utilisation chez un humain ou un mammifère
US9393291B2 (en) 2012-04-12 2016-07-19 Botulinum Toxin Research Associates, Inc. Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
RU2496150C1 (ru) * 2012-04-16 2013-10-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Омский государственный университет им. Ф.М. Достоевского" Способ моделирования костной кристаллизации при коксартрозе in vitro
US9492513B2 (en) * 2013-04-25 2016-11-15 Allergan, Inc. Methods for treatment of hip and groin pain associated with femoroacetabular impingement (FAI)
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US9901627B2 (en) 2014-07-18 2018-02-27 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
CN105567739B (zh) * 2016-02-04 2019-07-12 郑州可尔利尔生物科技有限公司 病毒载体颗粒及其构建方法和应用
BR112019004935A2 (pt) 2016-09-13 2019-06-04 Allergan, Inc. composições de toxina clostridial não proteíca estabilizada
GB201815844D0 (en) * 2018-09-28 2018-11-14 Ipsen Biopharm Ltd Therapeutic & comestic uses of botulinum neurotoxin serotype e

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9120306D0 (en) 1991-09-24 1991-11-06 Graham Herbert K Method and compositions for the treatment of cerebral palsy
RU2112446C1 (ru) * 1992-11-05 1998-06-10 Дагестанский государственный медицинский институт Способ лечения болезни пертеса
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
ES2332905T3 (es) 1993-12-28 2010-02-15 Allergan, Inc. Uso del componente neurotoxico de la toxina botulinica para el tratamiento de trastornos de musculos lisos.
US5721215A (en) * 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US6063768A (en) * 1997-09-04 2000-05-16 First; Eric R. Application of botulinum toxin to the management of neurogenic inflammatory disorders
TW574036B (en) * 1998-09-11 2004-02-01 Elan Pharm Inc Stable liquid compositions of botulinum toxin
US6464986B1 (en) * 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
US6423319B1 (en) * 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries

Also Published As

Publication number Publication date
AU2002222432B8 (en) 2006-04-27
EP1357937B1 (fr) 2005-03-23
JP2004517114A (ja) 2004-06-10
EP1357937A2 (fr) 2003-11-05
ITUD20010002A1 (it) 2002-07-05
CN1491115A (zh) 2004-04-21
RU2283664C2 (ru) 2006-09-20
CA2433765A1 (fr) 2002-07-11
CA2433765C (fr) 2008-10-28
US20070020294A1 (en) 2007-01-25
US20040071735A1 (en) 2004-04-15
DE60203370T2 (de) 2006-02-09
CY1105490T1 (el) 2010-04-28
US7208166B2 (en) 2007-04-24
DE60203370D1 (de) 2005-04-28
PT1357937E (pt) 2005-08-31
WO2002053175A2 (fr) 2002-07-11
CN1318089C (zh) 2007-05-30
RU2003124186A (ru) 2005-01-10
ES2242858T3 (es) 2005-11-16
AU2002222432B2 (en) 2006-04-13
ATE291437T1 (de) 2005-04-15
WO2002053175A3 (fr) 2002-09-12

Similar Documents

Publication Publication Date Title
DK1357937T3 (da) Anvendelse af botulintoxin til opnåelse af et produkt til anvendelse ved ledpatologier, navnlig coxarthrosis, epicondylitis og drejemuskelkappepatologi
PT1280541E (pt) Utilizacao de estirpes acetogenicas hidrogenotroficas para a prevencao ou o tratamento de disturbios digestivos
MX2010007357A (es) Puesta de anti-cuerpos en objetivo mediante un dominio de reconocimiento modular.
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
FI20010761A0 (fi) Menetelmä, järjestelmä ja laite äänestyksen suorittamiseksi
HRP20030089B1 (hr) Anti-tnf protutijela, pripravci, postupci i primjena
EP2153341A4 (fr) Système et procédé pour créer une communauté en ligne formant un réseau social
BRPI0313792B8 (pt) utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento
ATE304858T1 (de) Mischung enthaltend einen inhibitor oder suppressor eines gens und ein molekül,dass an ein expressionprodukt dieses gens bindet
MXPA04004563A (es) Telas no tejidas que tienen uniformidad de estrechamiento mejorada.
CU22776A3 (es) D-manitol y su preparación
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
DE60142913D1 (de) Arzneilösungen enthaltend modafinilverbindungen
DK1268066T3 (da) Pipette med forenklet demontering
FI20011649L (fi) Korkeapaineinen, suurnopeuksinen primäärinen ja sekundäärinen jalostus
IL152410A0 (en) Method for cell adhesion and wound healing
MXPA02007787A (es) Moleculas trade y uso relacionado con las mismas.
DE60115039D1 (de) Screeningverfahren für modulatoren von methyltransferase abhängiger chromosomenstabilität
Gunathilaka et al. Phytochemical Profile of Main Antioxidants in Different Fractions of Chnoospora Minima and Gracillaria Edulis
WO2002012283A3 (fr) Homologues de disintegrine, zsnk10, zsnk11, et zsnk12
Kornoukhova et al. A NEW GENERATION OF SWITCHES
CHAKRABARTI Minor Antiquities of India and their Role in the Life Pattern of Ancient Civilization–an Iinterpretation
Erić The problem of method in Bergsonism
UA32345A (uk) Спосіб кореляційно-оптичної ідентифікації тупих предметів у судово-медичній травматології
EA199800698A1 (ru) Способ лечения и фармацевтическая композиция